Lexaria Bioscience (LEXX) Stock Chart & Stock Price History → The Department of Defense Has a New Drone Contractor (From The Tomorrow Investor) (Ad) Free LEXX Stock Alerts $3.55 -0.05 (-1.39%) (As of 05/10/2024 08:55 PM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Lexaria Bioscience Stock Price Performance5 Day Performance+0.28%1 Month Performance+67.45%3 Month Performance+44.31%6 Month Performance+168.94%Year-To-Date Performance+184.00%1 Year Performance+370.82% Receive LEXX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Lexaria Bioscience and its competitors with MarketBeat's FREE daily newsletter Email Address Ad The Tomorrow InvestorThe Department of Defense Has a New Drone ContractorThe Department of Defense just granted a major advantage to a small UAV provider. Since 1998, this Nasdaq-listed company has been supplying drones for civilian, enterprise, and military purposes.Click here to see how to invest LEXX Stock Chart for Monday, May, 13, 2024 LEXX Chart by TradingView Lexaria Bioscience Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/10/2024$3.60$3.55-1.39%$4.00$3.52255,411 shs$45.76 million05/09/2024$3.54$3.60+1.69%$3.81$3.42190,024 shs$46.40 million05/08/2024$3.43$3.54+3.21%$3.56$3.34103,173 shs$45.63 million05/07/2024$3.41$3.43+0.59%$3.48$3.22226,517 shs$44.21 million05/06/2024$3.13$3.41+8.95%$3.51$3.20293,832 shs$43.94 million05/03/2024$3.00$3.13+4.33%$3.24$2.93110,863 shs$40.35 million Get the Latest News and Ratings for LEXX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lexaria Bioscience and its competitors with MarketBeat's FREE daily newsletter. 05/02/2024$3.49$3.00-14.04%$3.53$2.95185,054 shs$38.67 million05/01/2024$3.09$3.49+12.94%$3.68$3.06363,607 shs$44.97 million04/30/2024$2.46$3.09+25.61%$3.14$2.44646,792 shs$39.83 million04/29/2024$2.35$2.46+4.68%$2.49$2.32123,811 shs$31.71 million04/26/2024$2.19$2.35+7.31%$2.45$2.17172,105 shs$30.29 million04/25/2024$2.20$2.19-0.45%$2.30$2.1522,119 shs$28.23 million04/24/2024$2.24$2.20-1.79%$2.28$2.1897,910 shs$28.36 million04/23/2024$2.27$2.24-1.10%$2.30$2.2053,982 shs$28.87 million04/22/2024$2.20$2.27+2.95%$2.29$2.1934,357 shs$29.19 million04/19/2024$2.25$2.20-2.22%$2.29$2.1561,646 shs$28.36 million04/18/2024$2.34$2.25-3.85%$2.41$2.22124,707 shs$29.00 million04/17/2024$2.31$2.34+1.30%$2.73$2.25460,980 shs$30.15 million04/16/2024$1.99$2.31+16.08%$2.34$1.85295,779 shs$29.78 million04/15/2024$2.12$1.99-6.13%$2.14$1.91315,206 shs$25.65 million04/12/2024$2.51$2.12-15.54%$2.64$2.12455,728 shs$27.33 million04/11/2024$2.66$2.51-5.64%$2.72$2.50249,689 shs$31.07 million04/10/2024$2.70$2.66-1.48%$2.79$2.60143,381 shs$32.93 million04/09/2024$2.96$2.70-8.78%$3.03$2.65246,698 shs$33.43 million04/08/2024$3.05$2.96-2.95%$3.18$2.93155,255 shs$36.64 million04/05/2024$3.19$3.05-4.39%$3.29$3.05124,644 shs$37.76 million04/04/2024$3.41$3.19-6.45%$3.48$3.17269,046 shs$39.49 million04/03/2024$3.47$3.41-1.73%$3.57$3.23245,726 shs$42.21 million04/02/2024$3.42$3.47+1.46%$3.50$3.32134,442 shs$42.96 million04/01/2024$3.63$3.42-5.79%$3.82$3.25159,197 shs$42.34 million03/29/2024$3.63$3.63$3.92$3.59168,460 shs$44.94 million03/28/2024$3.71$3.63-2.16%$3.92$3.59168,193 shs$44.93 million03/27/2024$3.79$3.71-2.11%$3.91$3.60232,650 shs$45.93 million03/26/2024$3.95$3.79-4.05%$3.95$3.75234,085 shs$46.92 million03/25/2024$3.47$3.95+13.83%$4.00$3.41604,742 shs$48.90 million03/22/2024$3.44$3.47+0.87%$3.55$3.30186,345 shs$42.96 million03/21/2024$3.70$3.44-7.03%$3.96$3.36844,669 shs$42.59 million03/20/2024$4.00$3.70-7.50%$4.22$3.61403,269 shs$45.81 million03/19/2024$3.40$4.00+17.65%$4.17$2.991.09 million shs$49.52 million03/18/2024$3.90$3.40-12.82%$3.89$3.15818,051 shs$42.09 millionObama’s Forever Term [exposed] (Ad)America’s Last Election New documentary, America’s Last Election, reveals the true (and terrifying) story of how the D.C. establishment has engineered a brutal new crisis that could hand them permanent power. Power they will use to reshape America to their dark, dystopian vision.Start streaming it now at no cost here03/15/2024$3.85$3.90+1.30%$4.05$3.65464,304 shs$48.28 million03/14/2024$4.40$3.85-12.50%$4.49$3.75508,673 shs$47.66 million03/13/2024$4.18$4.40+5.26%$5.18$4.02996,390 shs$54.47 million03/12/2024$6.25$4.18-33.12%$6.45$3.363.63 million shs$51.75 million03/11/2024$5.50$6.25+13.64%$6.85$5.491.26 million shs$77.38 million03/08/2024$5.00$5.50+10.00%$6.01$5.051.53 million shs$57.42 million03/07/2024$4.48$5.00+11.61%$5.34$4.201.42 million shs$52.20 million03/06/2024$3.38$4.48+32.54%$4.50$3.451.36 million shs$46.77 million03/05/2024$3.00$3.38+12.67%$3.61$2.811.00 million shs$35.29 million03/04/2024$2.92$3.00+2.74%$3.25$2.75643,588 shs$31.31 million03/01/2024$3.45$2.92-15.36%$2.93$2.311.61 million shs$30.49 million02/29/2024$2.55$3.45+35.29%$3.45$2.651.02 million shs$36.00 million02/28/2024$2.40$2.55+6.25%$2.95$2.501.01 million shs$26.62 million02/27/2024$2.26$2.40+6.19%$2.75$2.26704,837 shs$25.06 million02/26/2024$2.21$2.26+2.26%$2.27$2.18137,988 shs$23.59 million02/23/2024$2.27$2.21-2.64%$2.25$2.0693,345 shs$23.07 million02/22/2024$2.25$2.27+0.89%$2.37$2.13290,370 shs$23.70 million02/21/2024$2.32$2.25-3.02%$2.30$2.22103,198 shs$23.49 million02/20/2024$2.14$2.32+8.41%$2.35$2.14205,246 shs$24.22 million02/19/2024$2.14$2.14$2.41$2.10428,500 shs$22.33 million02/16/2024$2.36$2.14-9.32%$2.41$2.10423,054 shs$22.34 million02/15/2024$2.60$2.36-9.23%$2.65$2.25432,591 shs$24.63 million02/14/2024$2.46$2.60+5.69%$2.78$2.40315,657 shs$27.13 million02/13/2024$2.27$2.46+8.37%$2.58$2.25233,028 shs$25.68 million02/12/2024$2.30$2.27-1.30%$2.42$2.21199,083 shs$23.70 million Related Companies: NXTC Stock Chart UNCY Stock Chart CARA Stock Chart SNSE Stock Chart NBRV Stock Chart IMRX Stock Chart XLO Stock Chart EYEN Stock Chart BOLT Stock Chart VYNE Stock Chart Receive LEXX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Lexaria Bioscience and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:LEXX) was last updated on 5/13/2024 by MarketBeat.com Staff From Our PartnersBill Clinton Backing Biden Replacement???The Freeport SocietyThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe Crypto 9-5 Escape PlanCrypto 101 MediaProtect Your Bank Account Before It’s Too LateWeiss RatingsCharles Payne Demystifies OptionsUnstoppable ProsperityElon’s New Device is About to Shock the WorldInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lexaria Bioscience Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.